Dimensional Fund Advisors’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-26,233
| Closed | -$43.8K | – | 3323 |
|
|
2024
Q4 | $43.8K | Sell |
26,233
-11,413
| -30% | -$19.1K | ﹤0.01% | 3301 |
|
|
2024
Q3 | $68.8K | Buy |
37,646
+3,103
| +9% | +$5.67K | ﹤0.01% | 3268 |
|
|
2024
Q2 | $208K | Sell |
34,543
-15,798
| -31% | -$95.1K | ﹤0.01% | 3158 |
|
|
2024
Q1 | $561K | Sell |
50,341
-83,881
| -62% | -$935K | ﹤0.01% | 3026 |
|
|
2023
Q4 | $2M | Sell |
134,222
-517
| -0.4% | -$7.7K | ﹤0.01% | 2791 |
|
|
2023
Q3 | $647K | Buy |
134,739
+45,367
| +51% | +$218K | ﹤0.01% | 3011 |
|
|
2023
Q2 | $671K | Sell |
89,372
-3,040
| -3% | -$22.8K | ﹤0.01% | 3003 |
|
|
2023
Q1 | $418K | Buy |
92,412
+13,135
| +17% | +$59.4K | ﹤0.01% | 3067 |
|
|
2022
Q4 | $893 | Buy |
79,277
+12,804
| +19% | +$144 | ﹤0.01% | 2922 |
|
|
2022
Q3 | $636K | Buy |
+66,473
| New | +$636K | ﹤0.01% | 2989 |
|